Zazzle Shop

Screen printing
Showing posts with label Genetics. Show all posts
Showing posts with label Genetics. Show all posts

Tuesday, August 2, 2011

Half of European men share King Tut's DNA


By Alice Baghdjian
From  http://af.reuters.com/




LONDON Aug 1 (Reuters Life!) - Up to 70 percent of British men and half of all Western European men are related to the Egyptian Pharaoh Tutankhamun, geneticists in Switzerland said.

Scientists at Zurich-based DNA genealogy centre, iGENEA, reconstructed the DNA profile of the boy Pharaoh, who ascended the throne at the age of nine, his father Akhenaten and grandfather Amenhotep III, based on a film that was made for the Discovery Channel.

The results showed that King Tut belonged to a genetic profile group, known as haplogroup R1b1a2, to which more than 50 percent of all men in Western Europe belong, indicating that they share a common ancestor.

Among modern-day Egyptians this haplogroup contingent is below 1 percent, according to iGENEA.

"It was very interesting to discover that he belonged to a genetic group in Europe -- there were many possible groups in Egypt that the DNA could have belonged to," said Roman Scholz, director of the iGENEA Centre.
Around 70 percent of Spanish and 60 percent of French men also belong to the genetic group of the Pharaoh who ruled Egypt more than 3,000 years ago.

"We think the common ancestor lived in the Caucasus about 9,500 years ago," Scholz told Reuters.

It is estimated that the earliest migration of haplogroup R1b1a2 into Europe began with the spread of agriculture in 7,000 BC, according to iGENEA.

However, the geneticists were not sure how Tutankhamun's paternal lineage came to Egypt from its region of origin.


The centre is now using DNA testing to search for the closest living relatives of "King Tut".

"The offer has only been publicised for three days but we have already seen a lot of interest," Scholz told Reuters. (Edited by Paul Casciato)

Friday, June 10, 2011

Chinese GM Cows Make Human Breast Milk

Holly Williams, Beijing correspondent

Dairy cows

Chinese scientists say human breast milk produced by cows is more nutritious than normal milk. Picture: AFP


Chinese scientists have genetically modified dairy cows to produce human breast milk, and hope to be selling it in supermarkets within three years.



The milk produced by the transgenic cows is identical to the human variety and has the same immune-boosting and antibacterial qualities as breast milk, scientists at China's Agricultural University in Beijing say.

The transgenic herd of 300 was bred by inserting human genes into cloned cow embryos which were then implanted into surrogate cows.

The technology was similar to that used to produce Dolly the sheep.

The milk is still undergoing safety tests but with government permission it will be sold to consumers as a more nutritious dairy drink than cow's milk.

Workers at the university's dairy farm have already tasted the milk, and say it is sweeter and stronger than the usual bovine variety.

There are 1.5 billion people in the world who don't get enough to eat. It's our duty to develop science and technology, not to hold it back. We need to feed people first, before we consider ideals and convictions.

Professor Li Ning, director of the research project

"It's good," said worker Jiang Yao. "It's better for you because it's genetically modified."

The scientists have also produced animals that are resistant to mad cow disease, as well as beef cattle that are genetically modified to produce more nutritious meat.

The director of the research project, Professor Li Ning, says Western concerns about the ethics of genetic modification are misplaced.

"There are 1.5 billion people in the world who don't get enough to eat," he said. "It's our duty to develop science and technology, not to hold it back.

"We need to feed people first, before we consider ideals and convictions."

In contrast to Europe, China has eagerly embraced genetically modified food.

GM cooking oil, papayas, tomatoes and potatoes are already widely available.

Insect-resistant rice and corn modified to help pigs absorb more nutrients were both recently approved by the government.

Thursday, December 23, 2010

'Singing Mouse' Made With Genetic Modification

From: http://news.discovery.com/

The tweeting mouse, created by triggering mutations, could help shed light on how language evolved.

Content provided by AFP

tweeting mouse
Japanese scientists said they have produced a mouse that tweets like a bird in a genetically engineered "evolution." Click to enlarge this image.

Osaka University

Japanese scientists said Tuesday they had produced a mouse that tweets like a bird in a genetically engineered "evolution" which they hope will shed light on the origins of human language.
A team of researchers at the University of Osaka created the animal in their "Evolved Mouse Project," in which they use genetically modified mice that are prone to miscopying DNA and thus to mutations.
"Mutations are the driving force of evolution. We have cross-bred the genetically modified mice for generations to see what would happen," lead researcher Arikuni Uchimura said.
"We checked the newly born mice one by one... One day we found a mouse that was singing like a bird," he said, noting that the "singing mouse" was born by chance but that the trait will be passed on to future generations.
Click here to see and hear the singing mouse.
"I was surprised because I had been expecting mice that are different in physical shape," he said by telephone, adding that in fact the project had also produced "a mouse with short limbs and a tail like a dachshund."
The laboratory, directed by professor Takeshi Yagi at the Osaka University's Graduate School of Frontier Biosciences in western Japan, now has more than 100 "singing mice" for further research.

The team hopes they will provide clues on how human language evolved, just as researchers in other countries study songbirds such as finches to help them understand the origins of human language.

Scientists have found that birds use different sound elements, put them together into chunks like words in human languages and then make strings of them to sing "songs," that are subject to certain linguistic rules.
"Mice are better than birds to study because they are mammals and much closer to humans in their brain structures and other biological aspects," Uchimura said.

"We are watching how a mouse that emits new sounds would affect ordinary mice in the same group... in other words if it has social connotations," he said, adding that ordinary mice squeak mainly under stress.
Considering that mutant mice tweet louder when put in different environments or when males are put together with females, Uchimura said their chirps "may be some sort of expressions of their emotions or bodily conditions."

The team has found that ordinary mice that grew up with singing mice emitted fewer ultrasounds than others, which could indicate that communication methods can spread in the same group like a dialect.
Uchimura dreams of further "evolution" of mice through genetic engineering.
"I know it's a long shot and people would say it's 'too absurd'... but I'm doing this with hopes of making a Mickey Mouse some day," he said.

Tuesday, June 15, 2010

Amazed Boffins Probe Ozzy's Genetic Code

Elizabeth Scott,
Sky News Online

Scientists are to map Ozzy Osbourne's genetic code in a bid to find out how he is still alive after decades of drug and alcohol abuse.

Ozzy Osbourne

Hard-living Ozzy Osbourne has admitted abusing drink and drugs for 40 years

The former Black Sabbath frontman is only one of a few people in the world to have his full genome analysed.

It is hoped the results from the £27,000 test, which takes three months, will provide information on how drugs are absorbed in the body.

Ozzy, 61, has lived a life that would presumably kill any ordinary person.

Even the singer himself cannot understand how he has survived this long, recently describing himself as a "medical miracle" after going on a "bender" for "40 years".

He has admitted drinking four bottles of cognac a day at one point, "blacking out, coming to again and carrying on".

Ozzy and Sharon Osbourne

Ozzy Osbourne with wife Sharon, who he once tried to strangle

Ozzy famously bit the head off a rat while performing with Black Sabbath and in 2003 broke his neck in a quad bike accident.

He also has a genetic disorder similar to Parkinson's disease and on at least one occasion has been committed to a mental institution.

Despite all his excesses, he is still with wife Sharon, who he once tried to strangle, and the couple have three grown-up children.

Now he may get some answers from US company Knome, which will use a blood sample to map his genome.

Nathan Pearson, director of research at the firm, said: "Sequencing and analysing individuals with extreme medical histories provides the greatest potential scientific value."

The results will hopefully help scientists understand why the bodies of hard-living rockers such as Ozzy, Keith Richards, Ronnie Wood and Iggy Pop are able to take more substance abuse than the average person.

Wednesday, March 17, 2010

Humans could regrow body parts like some amphibians

Regrowing amputated limbs, broken backs and even damaged brains could one day be a reality after scientists discovered a gene that is key to the almost magical ability.

Researchers have found that the gene p21 appears to block the healing power still enjoyed by some creatures including amphibians but lost through evolution to all other animals.

By turning off p21, the process can be miraculously switched back on.

Academics from The Wistar Institute in Philadelphia found that mice lacking the p21 gene gain the ability to regenerate lost or damaged tissue.

Unlike typical mammals, which heal wounds by forming a scar, these mice begin by forming a blastema, a structure associated with rapid cell growth.

According to the Wistar researchers, the loss of p21 causes the cells of these mice to behave more like regenerating embryonic stem cells rather than adult mammalian cells. This means they act as if they creating rather thane mending the body.

Their findings, published in the Proceedings of the National Academy of Sciences, provide solid evidence to link tissue regeneration to the control of cell division.

They turned off the gene in mice which had damaged ears and they regrew them. While they say it is early days, there is nothing theoretically different about applying the same process to humans.

Professor Ellen Heber-Katz, the lead scientist, said: "Much like a newt that has lost a limb, these mice will replace missing or damaged tissue with healthy tissue that lacks any sign of scarring.

"While we are just beginning to understand the repercussions of these findings, perhaps, one day we'll be able to accelerate healing in humans by temporarily inactivating the p21 gene.

"In normal cells, p21 acts like a brake to block cell cycle progression in the event of DNA damage, preventing the cells from dividing and potentially becoming cancerous.

"We propose that any future therapy would involve turning off p21 transiently during the healing process and only locally at the wound site. This might be done through locally applied drugs. This should minimise any side effects."

Friday, September 25, 2009

Core blimey! It's the red and green apple with a split personality

By Arthur Martin


When Ken Morrish picked this apple off a tree in his garden, he thought a prankster had painted half of it red.

But after inspecting it closely he realised that the remarkable split colours on the fruit were a natural phenomenon. And the bizarre apple turned Mr Morrish into something of a celebrity in his village with scores of neighbours queuing up to take a photograph of it.

Experts say that the odds of finding an apple with such a perfect line between the green and the red are more than 1million to one.

Enlarge The red and green apple

A fruit of two halves: This Golden Delicious apple seems to be having an identity crisis, split perfectly down the middle into red and green. Local horticulture experts are baffled by the specimen

But Mr Morrish, a retired painter and decorator who lives in Colaton Raleigh, near Sidmouth in Devon, has no plans to eat it.

Instead, he has stored it in his fridge so villagers can continue to come round and take photos.

'It looks as if a green apple and a red apple has been cut in half and stuck together,' he said. 'I couldn't believe my eyes. It's absolutely phenomenal.

The 72-year-old pensioner spotted the split-coloured fruit as he picked apples from a Golden Delicious tree in his garden.

Ken Morrish and the apple

One in a million: Ken Morrish could hardly believe his eyes when he saw the freaky fruit.

Horticulturists say the colourings on the apple are probably caused by a random genetic mutation.

In such cases, the red side usually tastes sweeter than the green side - because it has seen more sunshine during its growth.

Fact file

  • Mutations also occurs in other fruits and flowers. Last year a woman peeled back a banana skin and discovered the fruit was bright red inside.
  • If the genetic mutation took place within the apple, it is likely to be a one-off occurrence. However, if the mutation occurred in the tree, there could be similar coloured apples next year.
  • Even though it is half red, half green, the apple is still called as a Golden Delicious. Red Delicious apples are a different species and have not been interbred with the Golden Delicious species.
  • Mutations can sometimes be triggered by cold weather, temperature fluctuations or insect damage.

'The red and green split through the stem is totally perfect - as if I've painted it. It's a genuine one-off and none of us have ever seen an apple like it before.'

Mr Morrish, a grandfather-of-two who has grown apples for 45 years, took the fruit to horticultural experts at a nearby college for closer examination.

'They took pictures of it and said they had never come across anything like it either,' he added. 'It's caused a real stir in the village. People have been coming round to see it and take photos of it.

'I'm sure a few hundred years ago it would have been seen as a supernatural sign or something. I don't know if it's worth a lot of money but I won't be letting it out of my sight.'

John Breach, chairman of the British Independent Fruit Growers Association, said: 'I've never seen this happen before to a Golden Delicious. It is extremely rare. It is an extreme mutation.

'There has been the occasional case of this type reported. If there was a whole branch of apples with the same colouring then fruit experts would get even more excited.'

Jim Arbury, fruit superintendent at RHS Garden Wisley in Surrey, said it was probably the 'result of a random genetic mutation'.

'This is known as a chimera where one of the first two cells has developed differently giving rise to one half of the apple being different,' he said.

'It is unlikely to be a stable mutation but it is worth checking next year to see if it recurs. There are instances of some striped apples and pears where the mutation remains stable including one striped pear in the collection at Wisley called Pysanka.'

Wednesday, September 23, 2009

7 Intriguing Genetically Modified Fruits & VeggiesS

By Ecoist

montagefruitvegg-copy

Genetically modified food is one of great controversies of our time. Supporters point to wonderful possibilities of nutrient-packed food and solving world hunger, while critics fear unknown effects on human health. But whatever one’s opinion the matter, one thing is clear: some genetically modified fruits and vegetables are awfully intriguing! Here are 7 of the most interesting examples:

Graisins

graisin

(Image via Elanso)

The graisin (or giant raisin) is a raisin which has been genetically re-programmed to grow far beyond its normal size. It was produced by Japan’s National Institute of Genetics, which is unsurprising given that nation’s love for large fruits of all kinds. And while they taste exactly the same as small raisins, graisins are sure to make dinner guests stare in awe!

Grapples

grapple

(Image via Wikipedia)

Originally funded by UNICEF and created for Third World aid efforts, a grapple is simply a genetic cross between a grape and an apple. The fruit keeps the size and shape of the apple, the texture of the grape, and the flavor of both while providing a potent, high-strength dose of vitamin C.

Pluots

pluot

(Image via Palomar.edu)

Plums and apricots are delicious fruits in their own right, but combined, they form the genetically modified treat known as the pluot. Described by WiseGeek as “an intensely flavored fruit”, pluots are heavily fortified with vitamin C and have no sodium or cholesterol.

Tangelo

tangelo

(Image via TeamSugar)

“Should I have a tangerine or a grapefruit?” No longer need this question be asked! Lovers of each fruit can now get the best of both worlds with this sweet hybrid, which boasts a ton of fiber, vitamin C, and a slightly tart taste!

Colorful carrots

carrots

(Image via MSNBC)

Could colorful, genetically-modified carrots like those pictured here be the secret to absorbing more calcium? Two Texas researchers say yes – and they’ve created a carrot they claim allows people to absorb 40% more calcium than normal carrots to back up their claims!

Diabetes-fighting lettuce

lettuce

(Image via FloridaTrend)

Diabetes is one of the most frustrating and life-threatening illnesses out there. Living with it (at minimum) means daily, sometimes painful insulin injections – until now. University of Central Florida professor Henry Daniell has created a genetically modified strain of lettuce (pictured above) that carries the insulin gene. The lettuce cells protect the insulin on its journey through the digestive tract, and when the insulin reaches the intestines, the body’s natural insulin-producing response is triggered.

Lematos

lemato

(Image via FreeWebs)

Okay, so a lemon and a tomato aren’t the most natural of pairs, but that didn’t stop Israeli researchers from bringing us the Lemato! Unlike other genetically altered fruits and veggies (which were created primarily for health reasons), it appears that the lemato was solely an experiment to determine if it was possible to make tomatos give off the scent of lemons. Mission accomplished!

Monday, August 24, 2009

US doctor offers British couples chance to choose sex of child

Jeffrey Steinberg, a US doctor, is offering British couples the chance to choose the sex of their child at his New York clinic.

Dr Steinberg provoked anger earlier this year when he said his fertility clinic could allow parents to produce "designer babies" - choosing eye, hair, skin colour and gender.

Under American law, he is allowed to use pre-implentation genetic diagnosis (PGD) to reveal an embryo's sex. In Britain, it can only be used in screening for genetic diseases.

Half of the embryos undergoing tests in Dr Steinberg's laboratory reportedly belong to British couples while four more will be tested next month.

"Britain is far more conservative than it used to be. They were the innovators but now they've got handcuffs on," Dr Steinberg said.

"From a business standpoint, it's the best thing going. From a medical standpoint, it's a travesty."

America has allowed sex selection - known by its supporters as "family balancing" - since 2001, but US pro-life groups have criticised the destruction of embryos deemed undesirable. Earlier this year, the Pope attacked the "obsessive search for the perfect child" and said a "new mentality is creeping in that tends to justify a different consideration of life and personal dignity".

In Britain, officials have warned parents who go overseas for treatment - often after spotting advertisements on the internet - that they should understand the relevant laws and the impact of the selection on any child who is subsequently born.

Other American medical centres have reported receiving interest from British couples, including the Genetics and IVF Institute in Virginia.

The institute said that up to 15 per cent of the 400 PGD cases it handles a year come from abroad. It said it counsels parents before the procedure.

Gary Harton, its PGD scientific director, told The Times that he tells British patients: "You're no different to any other patient. You're here to get what you want. To get a baby."

Wednesday, August 12, 2009

Scientists Force Fungus to Have Sex to Create Biofuel

Fungus

Austrian scientists are putting the ‘fun’ in ‘fungus’ by forcing organisms which are usually asexual to have sex instead.

The hope is that the fungus would then be easier to breed, which would allow researchers to create organisms that are more efficient at degrading cellulose for the purpose of making biofuel.

Originally discovered in the Solomon Islands during World War II eating away at the canvas and garments of the U.S. Army, scientists have long known that the soil fungus Trichoderma reesei was particularly good at converting cellulose– a major component of plant biomass– into glucose. But until now it has been difficult for researchers to improve the fungus because it was believed to be asexual.

Due to the fact that sexual organisms exchange and mix their genetic material when they breed, their traits can be more easily manipulated artificially. Under the assumption that Trichoderma reesei was asexual, scientists looking to improve the fungus were instead limited to techniques like dosing the fungus with radiation or chemicals in order to alter its genetic profile. But that process only created random or unpredictable mutations.

But for the first time since its discovery 50 years ago, scientists can now make the fungus have sex.

Past studies have shown that Trichoderma reesei is genetically identical to another species of fungus, Hypocrea jecorina, which it so happens is capable of sexual reproduction. The primary difference between the two organisms was that Hypocrea jecorina seemed capable of assuming both the male and female roles, whereas Trichoderma reesei seemed only capable of assuming the male role.

So scientists got a novel idea: Why not breed the male-oriented Trichoderma with a female-oriented Hypocrea? The result was a successful mating– the Trichoderma lured into having sex could now be artificially selected for their advantageous genetic traits.

The findings could have largescale ramifications. Researchers want to employ the organisms to make use of the otherwise useless cellulose in sawdust, weeds and other plant scrap to make biofuel. Thus, the primary benefit of fungus sex could be to turn bush into biofuel. But the newly sexualized fungus can also help farmers. Since Trichoderma includes species that help plants by killing harmful fungi, they can be put to use protecting crops we use for food.

Source: LiveScience

Image Credit: V. Seidl, Vienna University of Technology

Monday, July 20, 2009

How Human Cloning Will Work

Introduction to How Human Cloning Will Work

Cloning Image Gallery

TIME cloning issue
Time & Life Pictures/­Getty Images
Hello, Dolly! After Dolly was cloned in 1997, people worried that humans would be next. See more cloning pictures.

­On July 5, 1997, the most famous sheep in modern history was born. Ian Wilmut and a group of Scottish scientists announced that they had successfully cloned a sheep named Dolly.

If you stood Dolly beside a "naturally" conceived sheep, you wouldn't notice any differences between the two. In fact, to pinpoint the only major distinguishing factor between the two, you'd have to go back to the time of conception because Dolly's embryo developed without the presence of sperm. Instead, Dolly began as a cell from another sheep that was fused via electricity with a donor egg. Just one sheep -- no hanky-panky involved.

While Dolly's birth marked an incredible scientific breakthrough, it also set off questions in the scientific and global community about what -- or who -- might be next to be "duplicated." Cloning sheep and other nonhuman animals seemed more ethically benign to some than potentially cloning people. In response to such concerns in the United States, President Clinton signed a five-year moratorium on federal funding for human cloning the same year of Dolly's arrival [source: Lamb].


­Today, after more than a decade since Dolly, human cloning remains in its infancy. Although cloning technology has improved, the process still has a slim success rate of 1 to 4 percent [source: ­Burton]. That being said, science is headed in that direction -- pending governmental restraints.

Scientists have cloned a variety of animals, including mice, sheep, pigs, cows and dogs. In 2006, scientists cloned the first primate embryos of a rhesus monkey. Then, in early 2­008, the FDA officially deemed milk and meat products from cloned animals and their offspring safe to eat.

But what would human cloning involve, and how could you take sperm out of the reproductive ­equation?

Creating a Human Clone

In January 2001, a small consortium of scientists led by Panayiotis Zavos, a former University of Kentucky professor, and Italian researcher Severino Antinori said that they planned to clone a human in two years [source: Kirby]. At about the same time, news surfaced about an American couple who planned to pay $500,000 to Las Vegas-based company Clonaid for a clone of their deceased infant daughter [source: Clonaid]. Neither venture produced documented success.

cloning
A breakdown of how cloning works.

Then, in 2004, South Korean scientist Hwang Woo-suk announced that he and his research team had cloned 11 human embryos for the purpose of extracting stem cells. However, after reviewing his work, a panel at Seoul National University concluded tha­t his findings were false. There ­hasn't been any confirmed human clone created to date. When discussing cloning in the sense of doing so to make a duplicate of an organism, we refer to it as reproductive cloning

Cloning Corner

­If human reproductive cloning proceeds, the primary method scientists will likely use is somatic ce­ll nuclear transfer (SCNT), which is the same procedure that was used to create Dolly the sheep. Somatic cell nuclear transfer begins when doctors take the egg from a female donor and remove its nucleus, creating an enucleated egg. A cell, which contains DNA, is taken from the person who is being cloned. Then the enucleated egg is fused together with the cloning subject's cell using electricity. This creates an embryo, which is implanted into a surrogate mother through in vitro fertilization.

If the procedure is successful, then the surrogate mother will give birth to a baby that's a clone of the cloning subject at the end of a normal gestation period. As mentioned before, the success rate for this type of procedure is small, working in only one or two out of every 100 embryos. After all, Dolly was the result of 277 previously failed attempts.

­On the surface, human cloning may evoke a similar reaction to the space program's race to the moon -- groundbreaking accomplishment, but what could we actually glean from it? Re-engineering the human reproductive process has made many people nervous that cloning crosses the ethical boundaries of science. But we can't fully evaluate the moral dilemma without first addressing the potential benefits of human cloning.

Cloning Uses

­At the outset of the clone craze, some scientists and companies focused on exploiting the science-fiction aspects of the technology. For instance, Zavos and Antinori, mentioned earlier, aimed to develop cloning to aid infertile couples -- to the tune of approximately $50,000 for the service. The group said that the procedure would involve injecting cells from an infertile male into an egg, which would be inserted into the female's uterus. This child would look the same as his or her father. Then there's the possibility of bringing deceased relatives back to life. A now-defunct company called Genetics Savings & Clone performed this type of cloning for a woman's dead cat, Little Nicky, in 2004.

Cloning on Film

Human reproductive cloning probably won't be a reality any time soon, but you can indulge your curiosity with a few cloning film selections.

  • The Island: Set in 2019, wealthy people keep clones of themselves on an island so if they ever get hurt, they can just snag a body part from their clone by murdering him or her.
  • The Boys from Brazil: If you like Gregory Peck, you may want to steer clear to preserve his old-school, dreamboat image. However, if you like movies about neo-Nazi cloning projects, get the popcorn ready!
  • Multiplicity: Doug Kinney has no time for anything, so he clones himself without telling his family -- let the hilarity ensue.

­Therapeutic cloning holds the most promise of valuable medical advancement. Therapeutic cloning is the process by which a person's DNA is used to grow an embryonic clone. However, instead of inserting this embryo into a surrogate mother, its cells are used to grow stem cells. These stem cells could become the basis for customized human repair kits. They can grow replacement organs, such as hearts, livers and skin. They can also be used to grow neurons to cure those who suffer from Alzheimer's, Parkinson's or Rett syndrome. And since the stem cells would come from embryo clones using your own cell's DNA, your body would readily accept them. For more detailed information on stem cells, you can read How Stem Cells Work.

Here's how therapeutic cloning works:

  • DNA is extracted from a sick person.
  • The DNA is then inserted into an enucleated donor egg.
  • The egg then divides like a typical fertilized egg and forms an embryo.
  • Stem cells are removed from the embryo.
  • Any kind of tissue or organ can be grown from these stem cells to treat various ailments and diseases.

To clone human embryos, however, you need eggs. If therapeutic cloning were to begin in earnest, it could increase the demand for such eggs and potentially create additional moral questions regarding the donors [source: Lamb]. Speaking of ethics, there's plenty of related debate to go around when it comes to human cloning.

Human Cloning Ethics

Surveys have shown that few Americans approve of cloning for reproductive purposes, although more are open to therapeutic cloning [source: Burton]. The U.S. government has established strategic roadblocks related to human cloning, although no federal ban exists. First, the government won't fund research focused on human cloning for reproduction. Also, the FDA, which regulates public cloning research, requires anyone in the United States attempting to clone humans to first get its permission. President George W. Bush's appointed Council on Bioethics unanimously opposed cloning for reproductive purposes.

twins at a table
Symphonie/Getty Images
Human reproductive cloning is banned in more than 50 countries.

Certain countries abroad have stricter standards, and more than 50 have legally banned research efforts on reproductive human cloning [source: Medical Devices & Surgical Technology]. In Japan, human cloning is a crime punishable by up to 10 years in prison. England has allowed cloning human embryos for therapeutic use only. Many individual states have also passed laws restricting cloning.

While legal restrictions are one deterrent to pursuing human cloning at this time, some scientists believe today's technology just isn't ready to be tested on humans. Ian Wilmut, one of Dolly's co-creators, has even said that human cloning projects would be irresponsible. Cloning technology is still in its early stages, and nearly 98 percent of cloning efforts end in failure. The embryos are either not suitable for implanting into the uterus, or die some time during gestation or shortly after birth.

Those clones that do survive suffer from genetic abnormalities. Clone cells may age more rapidly, shortening their lifespan, similar to what happened with Dolly. Some clones have been born with defective hearts, lung problems, diabetes, blood vessel complications and malfunctioning immune systems. One of the more famous cases involved a cloned sheep that was born but suffered from chronic hyperventilation caused by malformed arteries leading to the lungs.

­Opponents of cloning point out that while we can euthanize defective clones of other animals, it's morally problematic if this happens during the human cloning process. Advocates of cloning respond that it's now easier to pick out defective embryos before they're implanted into the mother. In 2005, the United Nations attempted to pass a global ban on human cloning, but was unsuccessful due to disagreements over whether therapeutic cloning should be included. For now, human cloning remains in a stalemate from both a scientific and public policy perspective -- the future of human cloning will likely depend on which side gives in first.

Sources

  • Burton, Kelli Whitlock. "Cloning in America." GeneWatch. November/December 2005.
  • Clonaid Web site.
    http://ww­w.clonaid.com/
  • "Cloning Fact Sheet." Human Genome Project Information. Updated July 23, 2008. (Sept. 3, 2008)
    http://www.ornl.gov/sci/techresources/Human_Genome/elsi/cloning.shtml#policy
  • "Human clones: New U.N. analysis lays out world's choices." Medical Devices & Surgical Technology Week. Dec. 2, 2007.
  • Javitt, Gail H.; Suthers, Kristen; and Hudson Kathy. "Cloning: A Policy Analysis." Genetics & Public Policy Center. May 23, 2005. (Sept. 3, 2008)
    http://www.pewtrusts.org/uploadedFiles/wwwpewtrustsorg/Reports/Genetics_and_Public_Policy/GPPC_Cloning_0505.pdf
  • Kirby, Alex. "Cloned human planned 'by 2003.'" BBC News. Jan. 30, 2001.
    http://news.bbc.co.uk/2/hi/science/nature/1144694.stm
  • Lamb, Gregory M. "How Cloning Stacks Up." Christian Science Monitor. July 13, 2006. (Sept. 3, 2008)
    http://www.csmonitor.com/2006/0713/p13s01-stgn.html
  • "Use of Cloning Technology to Clone a Human Being." FDA. Updated Dec. 27, 2002. (Sept. 3, 2008)
    http://www.fda.gov/CBER/genetherapy/clone.htm

Monday, June 8, 2009

The First GM Human Embryo Could Dramatically Alter the Future

Human_embryo “The advance of genetic engineering makes it quite conceivable that we will begin to design our own evolutionary progress.”

~Isaac Asimov, famous thinker and sci-fi writer

Cornell University researchers in New York revealed that they had produced what is believed to be the world’s first genetically altered human embryo—an ironic twist considering all the criticism the US has heaped on South Korea over the past several years for going “too far” with its genetic research programs. The Cornell team, led by Nikica Zaninovic, used a virus to add a green fluorescent protein gene, to a human embryo left over from an in vitro fertilization procedure. The research was presented at a meeting of the American Society of Reproductive Medicine last year, but details have emerged only after new controversy has emerged over the ethics and science of genetically modifying humans.

Zaninovic has pointed out that in order to be sure that the new gene had been inserted and the embryo had been genetically modified, scientists would ideally want to keep growing the embryo and carry out further tests. However, the Cornell team did not get permission to keep the embryo alive. The GM embryos created could theoretically have become the world’s first genetically altered man or woman, but it was destroyed after five days.

British regulators form the Human Fertilization and Embryology Authority (HFEA), have warned that such controversial experiments cause “large ethical and public interest issues”.

Much of the debate stems from the fact that the effects of genetically altering an embryo would be generational and permanent. In other words, if we create a mutant baby and it grows up to have children of it’s own—they’ll all be mutant gene carriers too. Genes injected into embryos and reproductive cells, such as sperm, affect every cells in the body and would be passed on to future generations. Critics say current humans don’t have the right to tamper with the gene pool of future generations.

On the other hand, proponents of such technology say that this science could potentially erase diseases such as cystic fibrosis, hemophilia and even cancer. In theory, any “good” gene could be added to embryos to offset any “bad” genes they are currently carrying. That could potentially mean the difference between life and death for many children.

John Harris, the Sir David Alliance Professor of Bioethics at Manchester University, takes it a step further. He believes that as parents, citizens, and scientists, we are morally obliged to do whatever we can genetically to make life better and longer for our children and ourselves. Society currently devotes so much energy and resources towards saving lives, which, in reality, is simply postponing death, he notes. If it is right to save life, Harris reasons, then it should also be right to postpone death by stemming the flow of diseases that carry us to the grave.

For Harris, having the ability to improve our species lot in life but refusing to do so, makes little sense. He has a difficult time understanding why some people are so insistent that we shouldn’t try to improve upon human evolution.

“Can you imagine our ape ancestors getting together and saying, ‘this is pretty good, guys. Let’s stop it right here!’. That’s the equivalent of what people say today.”

Ethicists, however, warn that genetically modifying embryos will lead to designer babies preloaded with socially desirable traits involving height, intelligence and coloring.

Dr David King, director of Human Genetics Alert, warns, “This is the first step on the road that will lead to the nightmare of designer babies and a new eugenics.”

Harris, however, doesn’t support that argument. He says it’s not about “beauty” it’s about health, and what parent wouldn’t want a healthy child, he asks.

“Certainly, sometimes we want competitive advantage [for our children], but for the enhancements I talk about, the competitive advantage is not the prime motive. I didn’t give my son a good diet in the hope that others eat a bad diet and die prematurely. I’m happy if everyone has a good diet. The moral imperative should be that enhancements are generally available because they are good for everyone.”

The only other route to equality, he says, is to level down so that everyone is as uneducated, unhealthy and unenhanced as the lowest in society – which would be much more unethical in his opinion. Even though we can’t offer a liver transplant to all who need them, he says, we still carry them out for the lucky few. “Much better to try to raise the baseline, even if some are left behind.”

The Human Fertilization and Embryology Bill in currently under consideration in Britain will likely make it legal to create GM embryos in that country, but only for research—implantation in the womb will still be banned—at least for now. However, ethicists believe that the legislation could easily be relaxed even further in the future.

People who believe that genetically modified humans is something way into the future might want to consider that many experts are worried that some forms of it are already happening in the sports world.

Faster, bigger, better, stronger—in theory, the single most effective way to radically alter your physical capacities is to manipulate your genes. Athletes are beginning to take notice. Now that we’ve mapped out the human genome and identified exactly which genes make you buff, tough and rough—experts are concerned about the future of genetic doping.

Gene doping could spawn athletes capable of out-running, out-jumping and out-cycling even the world’s greatest champions. However, researchers at the University of Florida are attempting to prevent that from happening by detecting the first cases of gene doping in professional athletes before the practice becomes mainstream.

Montreal-based World Anti-Doping Agency (WADA), responsible for monitoring the conduct of athletes, is working with investigators around the globe to develop testing to identify competitors who have injected themselves with genetic material that is capable of enhancing muscle mass or heightening endurance.

“If an athlete injects himself in the muscle with DNA, would we be able to detect that?” asked one of France’s leading gene therapy researchers, Philippe Moullier, M.D., Ph.D., director of the Gene Therapy Laboratory at the Universite de Nantes in France.

Right now, he says the answer is clearly “no”. But that may soon change. The UF scientists are among several groups collaborating with national and global anti-doping organizations to develop a test that can detect evidence of “doped” DNA.

“WADA has had a research program in place for some years now, to try to develop tests for gene-based doping,” said Theodore Friedmann, M.D., head of the agency’s panel on genetic doping and director of the gene therapy program at the University of California, San Diego.

Nearly every day now we are inundated with new genetic discoveries. Scientists can now pinpoint many specific genes including being lean, living a long life, improved self-healing, thrill seeking behavior, and having an improved memory among many other incredible traits. Many believe that these genes can be manipulated in ordinary humans, in effect creating Super-Mutants.

Theoretically, options are nearly limitless. Even a gene that exists in another species could be brought over to a human cell. Imagine some of the incredible traits of the animal kingdom that some humans don’t possess such as night vision, amazing agility, or the ability to breath underwater. The precedence for these types of radical changes is already in place. Experimental mice, for example, were successfully given the human ability to see in color. If animals can be engineered to have human traits, then humans can certainly be mutated to have desirable animal traits.

It is even thought possible to so drastically alter human genomes that a type of superhuman species could emerge. The fear with germline engineering is that since it is inheritable, offspring and all succeeding generations would carry the modified traits. This is one reason why this type of engineering is currently banned- it could lead to irreversible alteration of the entire human species.

Ethics, not scientific limitations, is the real brick wall. Most scientists believe manipulating genes in order to make an individual healthy is a noble and worthwhile pursuit. Some are against even that notion, arguing that historically amazing individuals have sometimes been plagued by genetic mental and physical disorders, which inadvertently shaped the greatness of their lives. Should we rob the human race of character shaping frailty? Very few scientists would dare to publicly endorse the idea of using genetic engineering to make a normal, healthy individuals somehow superior to the rest of the human race.

“The push to redesign human beings, animals and plants to meet the commercial goals of a limited number of individuals is fundamentally at odds with the principle of respect for nature,”
said Brent Blackwelder, President of Friends of the Earth in his testimony before the Senate Appropriations Committee.

However, would it be so bad if the human race were slightly improved? What if a relatively simple procedure could make an individual and his or her offspring resistant to cancer? After all, Nature isn’t always right. Nature has naturally selected many people to carry the burden of uncomfortable and often lethal genetic disorders. If nature knows best, then shouldn’t we quit trying to “improve” upon nature by “curing” people of genetic conditions we consider inferior? Many say we shouldn’t change human genetics, UNLESS it’s the RIGHT thing to do. Who gets to decide where the line is between righteous endeavor and the corruption of nature? These are the questions facing our generation.

Posted by Rebecca Sato

Tuesday, June 2, 2009

Gene Defect Corrected in Human Stem Cells

New research outlines a path toward new therapies with induced pluripotent stem cells.

For the first time, researchers have fixed the gene defect in cells from patients with an inherited disease, and then transformed the tissue into stem cells with the potential to reverse their condition. While scientists haven't yet tested the treatment in humans, the research could mark the beginning of a new age of curative treatments for many genetic disorders.

Correcting cells: Scientists corrected the genetic deficits in cells from patients with Fanconi anemia and then reprogrammed them into induced pluripotent stem cells. The cells can then be coaxed to differentiate into red blood cells. (Colonies of blood cells are shown at the bottom of the image.)
Credit: Juan Carlos Izpisua Belmonte

The proof of concept study, led by Juan Carlos Izpisua Belmonte at the Salk Institute for Biological Studies, in La Jolla, CA, focused on patients with a rare condition, Fanconi anemia, which causes skeletal problems and bone-marrow failure, and raises sufferers' risk of cancer.

Researchers took skin cells from six patients and used a virus to deliver a functional copy of one of the faulty genes responsible for the condition. The method had previously been shown to correct the gene defect in mice.

Next, researchers used cell programming techniques that have emerged in the past two years to transform the cells into stem cells capable of growing into any tissue type--including the healthy blood cells needed to correct the patients' inherited anemia. Known as induced pluripotent stem cell (iPS) reprogramming, this involves introducing four genes known to be active in the developing embryo, which in turn change the cells' pattern of gene expression to one that resembles an embryonic cell rather than an adult one.

"Our work demonstrates that it is possible to combine gene and cell therapy using iPS technology to generate disease-free cells," says Belmonte. The research was published online in the journal Natureon Sunday.

IPS cells are a particularly attractive medical tool for two key reasons. Unlike embryonic stem cells, iPS cells avoid the ethical controversy associated with harvesting human embryos. And because they come from the patient's own body, they will not be rejected by the immune system.

To test the therapy, scientists would need to grow blood progenitor cells from the genetically corrected iPS cells, and then transplant them back into patients, generating a supply of healthy blood cells. Belmonte notes, however, that the iPS cells that his team generated in the course of the study were not suitable for clinical use.

"Serious concerns need addressing before attempting any clinical trial with iPS-derived cells; perhaps the most important is that of tumor formation," says Belmonte. This is because the virally delivered genes used to reprogram the skin cells can remain embedded in the cell's DNA even after reprogramming. These genes are thought to become active during the cell-differentiation process, considerably raising the long-term risk of cancer.

In recent weeks, however, scientists have published two new methods of making iPS cells that do not involve viruses and thus may overcome this problem.

Experts say that the research is an important proof of concept. "This is an exciting bit of science," says Chris Mason, a professor of regenerative medicine at University College London, who was not directly involved in the research. "It's likely to be the first of a slew of similar papers that may offer hope for conditions where today there is no real therapy, let alone a cure."

So far, Belmonte's approach is applicable only to diseases in which the genetic defect that underlies the disease has been identified. "But there are quite a few of these--and the number will increase," says Mason. Blood disorders are likely to be the first targets for therapy because corrected cells can easily be transferred back to the patient via bone-marrow transplants.

Belmonte adds that in the future, the correction of more-complex genetic disorders might become possible, thereby significantly increasing the number of diseases that might be treated with altered iPS cells.

Thursday, May 28, 2009

Glowing Monkeys Make More Glowing Monkeys the Old-Fashioned Way

monkey_1

The first genetically modified primates that can pass their modifications to their offpsring have been created by Japanese scientists.

The marmosets, pictured above, express a green fluorescent protein in their skin. The gene for producing the glow was delivered to the first marmoset embryos via a modified virus. But now that modification method could become unnecessary. One male marmoset, number 666, fathered a child (pictured at right) that also contained the transgenes.

“The birth of this transgenic marmoset baby is undoubtedly a milestone,” developmental biologists Gerald Schatten and Shoukhrat Mitalipov at the Pittsburgh Development Center and Oregon Stem Cell Center, respectively wrote in a commentary accompanying the study Thursday in Nature. “The cumbersome and often frustrating process of making a transgenic animal from scratch need now only occur with founder animals.”

monkey_2Transgenic animals are a key tool in the biomedical researchers’ toolbox. They allow scientists to model the function of genes and the efficacy of treatments. Many transgenic mice lines exist, but often the small rodents are too different from humans to effectively extrapolate their responses to human beings. Primates, on the other hand, are far closer biologically to humans, but before the new technique, creating primate models had proven difficult and expensive.

Now, biologists may be able to produce whole groups of marmosets that mimic humans with genetic diseases like cystic fibrosis.

“Subsequent generations can be produced by natural propagation, with the eventual establishment of transgene-specific monkey colonies — a potentially invaluable resource for studying incurable human disorders, and one that may also contribute to preserving endangered primate species,” Schatten and Shoukhrat continued.

Instead of using bonobos or chimps, the research team led by Erika Sasaki at the Central Institute for Experimental Animals in Japan picked the common marmoset because its “size, availability, and unique biological characteristics” make it a potentially useful animal, particularly in tough fields like neuroscience and stem cell research.

Tuesday, May 19, 2009

13,000 offer up DNA to put their genomes online

Study among first to offer data to computer scientists

Lucas Mearian

Since opening to the public late last month, The Personal Genome Project has signed up 13,000 volunteers who will donate genetic material for the benefit of gene research worldwide. Information about the genetic material will also be posted online.

The project was launched last year with the goal of creating the world's first publicly accessible database of human genomic and trait data from 100,000 people. Initially, it started as a closed test study with 10 volunteers so that those who later sign up for the project "will know what they're getting into," said George Church, the Harvard Medical School professor leading the initiative.

Those first 10 volunteers had their genomes, along with photos and personal and family history, placed online as a pilot for the experiment, which one day could include millions of unique genomes.

Church said study participants have not been promised any anonymity -- just the opposite.

Participants are schooled on the fact that their private medical data, including any diseases or deformities, will be available for the world to view. And while Church acknowledged that will initially scare a some people off. But once people have gotten used to the idea of participating in medical research, "it's a fairly small additional step to say, 'Let's allow anyone at all to take a look at it.'

"We don't need that many people to enroll. One hundred thousand people out of 6.5 billion is a very tiny number of people," Church said.

The purpose of the public genome database is to offer up genetic information to the world's scientific community, including computer scientists, for the study of hereditary medical issues, according to Church. The project is among the first to allow researchers other than traditional medical doctors to use the data.

"I think there's a lot of opportunity for someone who looks at things differently to make connections that the so-called experts missed," he said. "So we're very excited about having participation of computer scientists, mathematicians, physicists and so forth."

Church believes that within a few years, everyone will have the opportunity to keep their own genome data -- and personal medical information -- in a personally-controlled electronic record. That valuable information becomes even more valuable when it can be shared with the scientific community in general.

"...If everyone shares, then suddenly it adds value to the resources everyone already has," he said.

The Personal Genome Project will focus initially on medical research. For example, Church and his team are interested in morphological characteristics, such as what makes a person's face the shape that it is.

"That doesn't sound like it's immediately medical, but things about morphology can affect whether you have sleeping or breathing problems," Church said. "We're trying not to be prejudicial in deciding in advance what's medical or not because there are opportunities for serendipity and holistic interconnections that computers can find that people may have missed because they're not as good at finding correlations."

To date, scientists have discovered 1,450 genes that are considered predictive of hereditary disease and that are actionable. That means a person with the genes can be treated medically if given enough warning or they can make a lifestyle change to make them less susceptible to illness, Church said.

The project targets families that have had diseases or abnormalities since their data will be of more use in finding genetic links. According to Church, older volunteers get priority because they've had more life history and more medical incidents.

Volunteers who sign up to have their genetic material tested must first answer a detailed questionnaire and demonstrate that they understand that their private information will be made very public. They will then be asked to give genetic material, such as hair, blood, skin or saliva, from which their genome will be extracted.

While volunteers won't have their names published with their genomic information, Church said the subjects are completely aware that anyone familiar with them can deduct from the photos and background information who they are.

A genome represents a full set of chromosomes -- or the complete genetic sequence -- of a human being, half of which come from the father and half from the mother. The genetic sequence represents 6 billion base pairs of nucleotides -- complementary DNA strands -- connected by hydrogen bonds.

A microsopic look at X and Y chromosomes that make up a genome.
The X and Y chromosomes that make up a genome.

In order to store the research data, one byte of capacity is required for each base pair. As a result, 6GB of data capacity is needed to store the genetic information of just one person, according to Church.

To address the scalability required for such a database, the project has turned to Web 2.0 technology and crowd sourcing. In other words, the project is being offered to the worldwide community of developers and technology vendors. For example, Isilon Systems Inc. stepped up to offer network-attached storage (NAS) clusters as primary storage for the project.

Church said Harvard went with NAS clusters because traditional monolithic storage arrays with RAID 5 protection is becoming less reliable for research where data grows exponentially. "We're starting to see solutions at that scale start to fail on a very regular basis," he said, "meaning you get two simultaneous disk failures and then lose whole data set."

Eventually, Church said he envisions millions of volunteers participating in the Personal Genome Project, requiring a highly scalable infrastructure. For just the current database with data on 10 people, the project is using 100 servers and a three-node Isilon IQ 12000x cluster.

The success of the project is highly dependent on how well the crowd-sourcing model works and which companies step forward to offer up technology for research. Church said Google has also offered "significant gifts," as has Amazon, which offered to host the data on its cloud storage offering.

Church said he expects The Personal Genome Project to have its 100,000 volunteers by the end of the year, even though not all of those participants will have been processed by that time.

"We're trying to build a model where even if only 100,000 out of 6.5 billion share, it's enough to benefit all 6 billion," he said.

Thursday, April 23, 2009

Fluorescent puppy is world's first transgenic dog


Ruppy the transgenic puppy at 10 days old. Even under natural light the red protein can be seen in the skin and fur. The next image shows Ruppy under ultraviolet light (Photo: Byeong Chun Lee)
Ruppy the transgenic puppy at 10 days old. Even under natural light the red protein can be seen in the skin and fur. The next image shows Ruppy under ultraviolet light (Photo: Byeong Chun Lee)

Enlarge image

2 more images

A cloned beagle named Ruppy – short for Ruby Puppy – is the world's first transgenic dog. She and four other beagles all produce a fluorescent protein that glows red under ultraviolet light.
A team led by Byeong-Chun Lee of Seoul National University in South Korea created the dogs by cloning fibroblast cells that express a red fluorescent gene produced by sea anemones.
Lee and stem cell researcher Woo Suk Hwang were part of a team that created the first cloned dog, SnuppyMovie Camera, in 2005. Much of Hwang's work on human cells turned out to be fraudulent, but Snuppy was not, an investigation later concluded.
This new proof-of-principle experiment should open the door for transgenic dog models of human disease, says team member CheMyong Ko of the University of Kentucky in Lexington. "The next step for us is to generate a true disease model," he says.
However, other researchers who study domestic dogs as stand-ins for human disease are less certain that transgenic dogs will become widespread in research.
Dogs already serve as models for diseases such as narcolepsy, certain cancers and blindness. And a dog genome sequence has made the animals an even more useful model by quickening the search for disease-causing genes. Most dog genetics researchers limit their work to gene scans of DNA collected from hundreds of pet owners.

Making a glowing dog

Lee's team created Ruppy by first infecting dog fibroblast cells with a virus that inserted the fluorescent gene into a cell's nucleus. They then transferred the fibroblast's nucleus to another dog's egg cell, with its nucleus removed. After a week dividing in a Petri dish, researchers implanted the cloned embryo into a surrogate mother.
Starting with 344 embryos implanted into 20 dogs, Lee's team ended up with seven pregnancies. One fetus died about half way through term, while an 11-week-old puppy died of pneumonia after its mother accidentally bit its chest. Five dogs are alive, healthy and starting to spawn their own fluorescent puppies, Ko says.
Besides the low efficiency of cloning – just 1.7 per cent of embryos came to term – another challenge to creating transgenic dogs is controlling where in the nuclear DNA a foreign gene lands. Lee's team used a retrovirus to transfer the fluorescent gene to dog fibroblast cells, but they could not control where the virus inserted the gene.
This would seem to prevent researchers from making dog "knockouts" lacking a specific gene or engineering dogs that produce mutant forms of a gene. These knockout procedures are now commonly done in mice and rats, and three researchers earned a Nobel prize in 2007 for developing this method, called "gene targeting".

No bright future?

Ko is working to adapt a procedure used so far in pigs, cows and other animals to target genes in cloned dogs. His lab hopes to knock out a specific oestrogen receptor in dogs to understand the hormone's effects on fertility.
The long lifespan of dogs and their reproductive cycle could make them more relevant to human fertility than mice, he says. "I think these dogs will be a very useful model for our research."
Greg Barsh, a geneticist at Stanford University who studies dogs as models of human disease, says creating a transgenic dog is "an important accomplishment", showing that cloning and transgenesis can be applied to a wide range of mammals.
"I do not know of specific situations where the ability to produce transgenic dogs represents an immediate experimental opportunity," Barsh adds. But transgenic dogs will give researchers another potential tool to understand disease.
However, Nathan Sutter, a geneticist specialising in dogs at Cornell University in Ithaca, New York, says "transgenesis is labourious, expensive and slow".
Add the expense of caring for laboratory-reared dogs and negative public perceptions and it could mean few researchers turn to transgenic dogs like Ruppy, he says: "it's not on my horizon as a dog geneticist at all."
Journal reference: genesis (DOI: 10.1002/dvg.20504)

Fertility expert: 'I can clone a human being'

Controversial doctor filmed creating embryos before injecting them into wombs of women wanting cloned babies

By Steve Connor, Science Editor


Cady, died aged 10 in a car crash in the US. Her blood cells were frozen and sent to Dr Zavos, who fused them with cow eggs to create cloned human animal hybrid embryos

Cady, died aged 10 in a car crash in the US. Her blood cells were frozen and sent to Dr Zavos, who fused them with cow eggs to create cloned human animal hybrid embryos

    Tuesday, April 21, 2009

    World's first cloned camel unveiled in Dubai

    The ambitious desert emirate of Dubai has claimed another first, this time in the science of cloning camels.

    By Richard Spencer in Dubai
    Injaz camel: Dubai claims world's first cloned camel
    Injaz, claimed to be the world's first cloned camel. Injaz, a female, was born on April 8, 2009 Photo: AFP

    Injaz, or Achievement, was unveiled to the world alongside her surrogate mother five days after being born at the city's Camel Reproduction Centre.

    "This is the first time scientists have cloned a camel calf," the scientific director of the central veterinary research laboratory, Dr Ulrich Wernery, said. "She is a healthy female."

    The project had the personal backing of Dubai's ruler, Sheikh Mohammed bin Rashid al-Maktoum, best known in Britain as one of the world's leading racehorse owners.

    The Camel Reproduction Centre now hopes to use the technique on some of Dubai's leading racing camels to preserve elite bloodlines for the future.

    Camel racing is a popular past-time in the Gulf region, though the traditional child riders have largely been replaced by robots due to humanitarian concerns.

    "We are all very excited by the birth of Injaz," Dr Lulu Skidmore, the centre's scientific director, said. "This significant breakthrough in our research programme gives a means of preserving the valuable genetics of our elite racing and milk-producing camels in the future."

    The scientists employed the standard animal cloning techniques first used in the case of Dolly the sheep in 1996 by scientists in Edinburgh.

    Injaz is the clone of a camel slaughtered for its meat in 2005. The ovaries were removed and DNA extracted and placed in an egg taken from and re-implanted into the surrogate mother.

    Tests since Injaz's birth have shown the camel's DNA to be a copy of the dead animal, not the mother.

    The birth, after an "uncomplicated" gestation period of 378 days, followed a number of unsuccessful attempts at producing a clone.

    The Camel Reproduction Centre previously produced the world's first "Cama", the first surviving hybrid of a camel and a guanaco, a type of llama.

    Friday, April 3, 2009

    Crazy genetics: Can chickens turn back into dinosaurs?



    fora.tv — A look back at our own history, and a question about creating a really tiny dinosaur. Do you think this could be possible?

    Thursday, March 12, 2009

    Unlocking the Secrets of Gray Hair

    Stuart Bradford


    When we start getting gray hair, we tend to blame stress — a high-pressure job, an illness, even our unruly children.

    But the link between gray hair and psychological stress is little more than folk wisdom, unsupported by numerous scientific studies. That didn’t stop widespread speculation last week, in The New York Times and elsewhere, that the newly noticed salt and pepper above President Obama’s temples were the first physical manifestations of some of the highest job pressures on the planet.

    A more likely explanation is that Mr. Obama is starting to turn gray for the same reasons other people do. He’s getting older. The age of graying seems to be determined by heredity, The Journal of Investigative Dermatology reported in 2005. Whites tend to gray first, often as early as their mid-30s, followed by Asians and then Africans. About half of 50-year-olds are at least 50 percent gray. So it would seem that Mr. Obama, at 47, is a little late to the graying game.

    But while the arrival of gray hair is relatively predictable, how and why hair ages this way is not well understood. Unlocking those secrets could have potential well beyond vanity, leading to a better understanding of the aging process at the cellular level. Scientists even hope that by identifying the mechanism that kills hardy hair-pigment cells and leaves us awash in gray, they can develop new treatments for shutting down more troublesome cells — like those that cause skin cancer.

    Last month, a team of European researchers achieved something of a eureka moment. They had been studying a genetic defect called vitiligo, which results in patches of skin that have no pigment. People with vitiligo (vit-uh-LYE-go) have low activity of catalase, an enzyme that breaks down hydrogen peroxide, resulting in elevated levels of hydrogen peroxide in the skin.

    Given that graying hair results from an absence of pigment, it occurred to the scientists that hydrogen peroxide and catalase might play a critical role in the process. Every hair cell makes a little hydrogen peroxide, but over time the amount builds up. The European team discovered that this buildup ended up blocking the normal synthesis of melanin, the natural pigment in hair.

    Our hair, it turns out, bleaches itself from the inside out. And by identifying the chemicals involved, researchers may be closer to understanding if the graying is influenced by stress.

    “Now it becomes possible to understand whether stress is involved in the process; before this, we didn’t know what to look for,” said Dr. Gerald Weissmann, research professor at the N.Y.U. School of Medicine and editor in chief of The FASEB Journal, which published the study last month. (The initials stand for Federation of American Societies for Experimental Biology.)

    But even if scientists find a link between psychological stress and graying, it’s quite likely that genetic factors ultimately determine who is susceptible.

    “Clearly our genetic makeup comes into the game,” said the European study’s lead author, Dr. Karin U. Schallreuter, professor of clinical and experimental dermatology at the University of Bradford in England. “Some are more susceptible and some are not. There are people around who still have black hair in the late periods of life.”

    The role of hydrogen peroxide is likely to be only a piece of the gray-hair puzzle. What’s intriguing about skin and hair cells is that while most of the body’s cells are programmed to turn themselves off when exposed to harmful stresses, certain skin and hair cells are much tougher. A few years ago, Harvard researchers reported that graying occurred when the stem cells that govern hair coloring lost their hardiness and shut down. The hope is that research into those cells may ultimately lead to treatments for melanoma, a skin cancer that can be fatal.

    One of the many mysteries of gray-hair research is why some people have salt-and-pepper hair. “If it was purely based on one’s antioxidant system or the ability to handle oxidative stress, then you still have to explain why some follicles can produce perfectly pigmented hairs in a sea of white hairs,” said Desmond J. Tobin, associate dean of research and knowledge transfer at the University of Bradford.

    Dr. Tobin notes that the skin is the only major organ that is directly exposed to environmental stress outside the body and the changing environment inside the body.

    “Skin and hair follicles are very important as an accessible test tube to look at for aging,” he said.

    Notably, scientists haven’t found a link between signs of aging in hair and real aging in the body. A major study of 20,000 men and women in Copenhagen looked for any links between heart-disease mortality and physical signs of aging like gray hair, baldness and facial wrinkles. They found none.

    “People with premature graying of the hair don’t die any sooner than anybody else,” said Dr. Leo M. Cooney, professor and chief of geriatrics at Yale University School of Medicine. “I think the study shows that gray hair has something to with your genetics and very little to do with premature aging.”